UniProt P02768
Serum albumin (P02768)
Serum albumin (UniProt P02768): 239 experimental structures and 1 predicted model on GenesisL1, 48 ligands bound, 73 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P02768
- Protein
- Serum albumin
- Experimental structures
- 239
- Predicted models
- 1
- Ligands
- 48
- Pockets
- 73 · 7 records with a druggable one
Structures
240 records of P02768 in the MolNFT archive: 239 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1AO6 | Crystal structure of human serum albumin | x-ray diffraction | A, B | — | — |
| 1AO6 | Crystal structure of human serum albumin | x-ray diffraction | A, B | — | — |
| 1BJ5 | Human serum albumin complexed with myristic acid | x-ray diffraction | A | — | — |
| 1BJ5 | Human serum albumin complexed with myristic acid | x-ray diffraction | A | — | — |
| 1BKE | Human serum albumin in a complex with myristic acid and tri-iodobenzoic acid | x-ray diffraction | A | — | — |
| 1BKE | Human serum albumin in a complex with myristic acid and tri- iodobenzoic acid | x-ray diffraction | A | — | — |
| 1BM0 | Crystal structure of human serum albumin | x-ray diffraction | A, B | — | — |
| 1BM0 | Crystal structure of human serum albumin | x-ray diffraction | A, B | — | — |
| 1E78 | Crystal structure of human serum albumin | x-ray diffraction | A, B | — | — |
| 1E78 | Crystal structure of human serum albumin | x-ray diffraction | A, B | — | — |
| 1E7A | Crystal structure of human serum albumin complexed with the general anesthetic propofol | x-ray diffraction | A, B | — | — |
| 1E7A | Crystal structure of human serum albumin complexed with the general anesthetic propofol | x-ray diffraction | A, B | — | — |
| 1E7B | Crystal structure of human serum albumin complexed with the general anesthetic halothane | x-ray diffraction | A, B | — | — |
| 1E7B | Crystal structure of human serum albumin complexed with the general anesthetic halothane | x-ray diffraction | A, B | — | — |
| 1E7C | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID and the general anesthetic halothane | x-ray diffraction | A | — | — |
| 1E7C | Human serum albumin complexed with myristic acid and the general anesthetic halothane | x-ray diffraction | A | — | — |
| 1E7E | Human serum albumin complexed with decanoic acid (capric acid) | x-ray diffraction | A | — | — |
| 1E7E | Human serum albumin complexed with decanoic acid (capric acid) | x-ray diffraction | A | — | — |
| 1E7F | Human serum albumin complexed with dodecanoic acid (lauric acid) | x-ray diffraction | A | — | — |
| 1E7F | Human serum albumin complexed with dodecanoic acid (lauric acid) | x-ray diffraction | A | — | — |
| 1E7G | Human serum albumin complexed with tetradecanoic acid (myristic acid) | x-ray diffraction | A | — | — |
| 1E7G | Human serum albumin complexed with tetradecanoic acid (myristic acid) | x-ray diffraction | A | — | — |
| 1E7H | Human serum albumin complexed with hexadecanoic acid (palmitic acid) | x-ray diffraction | A | — | — |
| 1E7H | Human serum albumin complexed with hexadecanoic acid (palmitic acid) | x-ray diffraction | A | — | — |
| 1E7I | Human serum albumin complexed with octadecanoic acid (stearic acid) | x-ray diffraction | A | — | — |
| 1E7I | Human serum albumin complexed with octadecanoic acid (stearic acid) | x-ray diffraction | A | — | — |
| 1GNI | HUMAN SERUM ALBUMIN COMPLEXED WITH cis-9-OCTADECENOIC ACID (OLEIC ACID) | x-ray diffraction | A | — | — |
| 1GNI | Human serum albumin complexed with cis-9-octadecenoic acid (oleic acid) | x-ray diffraction | A | — | — |
| 1GNJ | HUMAN SERUM ALBUMIN COMPLEXED WITH cis-5,8,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID) | x-ray diffraction | A | — | — |
| 1GNJ | Human serum albumin complexed with cis-5,8,11,14-eicosatetraenoic acid (arachidonic acid) | x-ray diffraction | A | — | — |
| 1H9Z | Human Serum Albumin Complexed With Myristic Acid and the R-(+) enantiomer of warfarin | x-ray diffraction | A | — | — |
| 1H9Z | Human serum albumin complexed with myristic acid and the R-(+) enantiomer of warfarin | x-ray diffraction | A | — | — |
| 1HA2 | Human Serum Albumin Complexed With Myristic Acid and the S-(-) enantiomer of warfarin | x-ray diffraction | A | — | — |
| 1HA2 | Human serum albumin complexed with myristic acid and the S-(-) enantiomer of warfarin | x-ray diffraction | A | — | — |
| 1HK1 | Human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-L-thyronine) | x-ray diffraction | A | — | — |
| 1HK1 | Human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-L- thyronine) | x-ray diffraction | A | — | — |
| 1HK2 | Human serum albumin mutant R218H complexed with thyroxine (3,3',5,5'-tetraiodo-L-thyronine) | x-ray diffraction | A | — | — |
| 1HK2 | Human serum albumin mutant R218H complexed with thyroxine (3,3',5,5'- tetraiodo-L-thyronine) | x-ray diffraction | A | — | — |
| 1HK3 | Human serum albumin mutant r218p complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) | x-ray diffraction | A | — | — |
| 1HK3 | Human serum albumin mutant R218P complexed with thyroxine (3,3',5,5'- tetraiodo-L-thyronine) | x-ray diffraction | A | — | — |
| 1HK4 | HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) and myristic acid… | x-ray diffraction | A | — | — |
| 1HK4 | Human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-L-thyronine) and myristic acid… | x-ray diffraction | A | — | — |
| 1HK5 | HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) and… | x-ray diffraction | A | — | — |
| 1HK5 | Human serum albumin mutant R218H complexed with thyroxine (3,3',5,5'-tetraiodo-L-thyronine) and… | x-ray diffraction | A | — | — |
| 1N5U | X-ray study of human serum albumin complexed with heme | x-ray diffraction | A | — | — |
| 1N5U | X-ray study of human serum albumin complexed with heme | x-ray diffraction | A | — | — |
| 1O9X | Human serum albumin complexed with tetradecanoic acid (myristic acid) and hemin | x-ray diffraction | A | — | — |
| 1O9X | Human serum albumin complexed with tetradecanoic acid (myristic acid) and hemin | x-ray diffraction | A | — | — |
| 1TF0 | Crystal structure of the GA module complexed with human serum albumin | x-ray diffraction | A | — | — |
| 1TF0 | Crystal structure of the ga module complexed with human serum albumin | x-ray diffraction | A | — | — |
| 1UOR | X-ray study of recombinant human serum albumin. phases determined by molecular replacement method… | x-ray diffraction | A | — | — |
| 1UOR | X-ray study of recombinant human serum albumin. phases determined by molecular replacement method… | x-ray diffraction | A | — | — |
| 1YSX | Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand… | solution nmr | A | — | — |
| 1YSX | Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand… | solution nmr | A | — | — |
| 2BX8 | Human serum albumin complexed with azapropazone | x-ray diffraction | A, B | — | — |
| 2BX8 | Human serum albumin complexed with azapropazone | x-ray diffraction | A, B | — | — |
| 2BXA | Human serum albumin complexed with 3-carboxy-4-methyl-5-propyl-2- furanpropanoic acid (CMPF) | x-ray diffraction | A, B | — | — |
| 2BXA | Human serum albumin complexed with 3-carboxy-4-methyl-5- propyl-2-furanpropanoic acid (cmpf) | x-ray diffraction | A, B | — | — |
| 2BXB | Human serum albumin complexed with oxyphenbutazone | x-ray diffraction | A, B | — | — |
| 2BXB | Human serum albumin complexed with oxyphenbutazone | x-ray diffraction | A, B | — | — |
180 records more on the page itself.
Ligands
- MYR · Myristic acid · in 14 records
- PLM · Palmitic acid · in 8 records
- PO4 · Phosphate ion · in 8 records
- GOQ · 8-methoxy-6-nitro-naphtho[1,2-e][1,3]benzodioxole-5-carboxylic acid · in 3 records
- OCA · Octanoic acid (caprylic acid) · in 3 records
- 8ZR · ~{N},~{N},12-trimethyl-3$l^{3}-thia-1$l^{4},5,6$l^{4}-triaza-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-amine · in 2 records
- 9SC · 7-[4-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one · in 2 records
- CPT · Cisplatin · in 2 records
- F8F · (2S,5S)-5-azanyl-3,4,6-tris(oxidanyl)oxane-2-carboxylic acid · in 2 records
- F8X · 2-amino-2-deoxy-beta-D-altropyranuronic acid · in 2 records
- GOR · 6-nitronaphtho[1,2-e][1,3]benzodioxole-5-carboxylic acid · in 2 records
- JEF · O-(O-(2-aminopropyl)-O'-(2-methoxyethyl)polypropylene glycol 500) · in 2 records
- M12 · 10-methylundecanoic acid · in 2 records
- SO4 · Sulfate ion · in 2 records
- UNL · Unknown ligand · in 2 records
- WOO · beta-L-allopyranose · in 2 records
- 4TX · 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid · in 1 record
- 6A4 · (4S)-2-sulfanylidene-4-[(tetradecanoyloxy)methyl]-1,3,2lambda~5~-dioxaphospholane-2-thiolate · in 1 record
- 6AK · 4-{8-chloro-11-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1-oxo-7-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,5-dihydro-1H-[1,4]diazepino[1,2-a]indol-2(3H)-yl}-1-methyl-1H-indole-6-carboxylic acid · in 1 record
- 7GE · pentakis(chloranyl)-(1~{H}-indazol-2-ium-2-yl)ruthenium(1-) · in 1 record
- 9KL · (2S)-2-[3-(benzenecarbonyl)phenyl]propanoic acid · in 1 record
- BR · Bromide ion · in 1 record
- BUA · butanoic acid · in 1 record
- C7K · 12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanoic acid · in 1 record
- CL · Chloride ion · in 1 record
- CLT · 4-phenyl-butanoic acid · in 1 record
- DAO · Lauric acid · in 1 record
- DIB · 3-amino-(dimethylpropylamine) · in 1 record
- E5O · 2-bromanyl-9-ethyl-~{N},~{N},7-trimethyl-3-thia-1$L^{4},5,6$L^{4},10-tetraza-2$L^{4}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(8),4,6,9,11-pentaen-4-amine · in 1 record
- EIC · Linoleic acid · in 1 record
Experiment against prediction
- 8Z8V chain A against the predicted model P02768: TM-score 0.99, RMSD 0.86 Å
- 2BXA chain A against the predicted model P02768: TM-score 0.99, RMSD 0.92 Å
- 2BXA chain A against the predicted model P02768: TM-score 0.99, RMSD 0.92 Å
- 2BXH chain A against the predicted model P02768: TM-score 0.99, RMSD 0.98 Å
- 2BXH chain A against the predicted model P02768: TM-score 0.99, RMSD 0.98 Å
- 2YDF chain A against the predicted model P02768: TM-score 0.99, RMSD 0.96 Å
- 2YDF chain A against the predicted model P02768: TM-score 0.99, RMSD 0.96 Å
- 2YDF chain B against the predicted model P02768: TM-score 0.99, RMSD 0.96 Å
- 2YDF chain B against the predicted model P02768: TM-score 0.99, RMSD 0.96 Å
- 2BXA chain B against the predicted model P02768: TM-score 0.99, RMSD 0.99 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.